| Floor Price | ₹2,189.73Per Share |
|---|---|
| Market Cap | ₹6,538.75 CrSpecialty Chemicals |
| Revenue TTM | ₹925.53 CrLTM to June 2026 |
| RSI | 59.26Neutral Zone |
Key highlights
- QIP floor price set at ₹2,189.73 per equity share, with a potential discretionary discount of up to 5%
- Relevant date for pricing the issue was fixed as September 10, 2026, by the Fund-Raising Committee
- Fundraise supports an ongoing ₹1,795 crore capital outlay for battery-grade lithium materials
- Proceeds will enhance liquidity for the Dahej Phase 1 and Pakhajan Phase 2 expansion projects
- Company recently reported a 66.76% YoY growth in net profit for the quarter ended June 2026
Details of the Fund Raise
The Fund-Raising Committee of Neogen Chemicals has authorized the opening of its Qualified Institutional Placement today, September 10, 2026. The committee approved a floor price of ₹2,189.73 per equity share, determined in accordance with SEBI ICDR Regulations. Under current guidelines, the company may offer a discount of up to 5% on this floor price at its discretion.
This placement follows earlier board and shareholder approvals for raising up to ₹600 crore to strengthen the balance sheet and support strategic growth initiatives. The issue price will be finalized in consultation with appointed lead managers.
Strategic Pivot and Capex Plans
- Aggregate capital outlay of ₹1,795 crore earmarked for the lithium battery materials business
- Strategic technology tie-up with MU Ionic Solutions (MUIS), Japan, for electrolyte manufacturing
- Development of a 30,000 MTPA electrolyte plant and 3,000 MTPA lithium salt capacity at Pakhajan
- Targeting a long-term revenue potential of ₹2,400 crore to ₹2,900 crore from battery chemicals by FY29
- Commissioning of the Pakhajan greenfield facility is scheduled for completion by March 2027
Financial Context and Performance
Neogen Chemicals enters this fundraise with strong operational momentum, reporting a 34.04% increase in Q1 FY27 revenue to ₹250.29 crore. The inorganic chemicals segment, which includes lithium salts, was a primary growth driver with a triple-digit volume increase of 154% during the same period. While net profit for the trailing twelve months stands at ₹35.56 crore, the company has faced temporary margin pressure due to higher finance costs related to its intensive capital expenditure.
Despite a recent rating moderation citing increased debt levels, the company maintains a stable business profile with a diversified basket of over 250 products across bromine and lithium derivatives.
Industry Trends in Specialty Chemicals
The specialty chemicals sector in India is currently benefiting from a structural shift toward localized sourcing and the 'China Plus One' strategy. Significant government incentives under the Advanced Chemistry Cell (ACC) PLI scheme are catalyzing demand for indigenous battery materials. Neogen is positioning itself as a first-mover in this space to cater to a projected electrolyte demand of over 150,000 MT by 2030.
As major domestic cell manufacturers begin scaling operations, integrated players with validated chemical processing capabilities are expected to play a critical role in the electric vehicle supply chain.
| Share price | ₹2388 |
|---|---|
| Market capitalisation | ₹6,538.75 Cr |
| Revenue (annual) | ₹861.96 Cr |
| Net profit (annual) | ₹28.75 Cr |
| Revenue (latest quarter) | ₹250.29 Cr+1.51% vs previous quarter |
| Net profit (latest quarter) | ₹17.11 Cr+50.22% vs previous quarter |
| P/E (TTM) | 183.88×Sector 38.05× |
| Promoter holding | 53.01%+1.78% QoQ |
| FII holding | 4.11%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Neogen Chemicals Limited announcing the opening of its Qualified Institutional Placement and the fixing of the floor price. Market figures from a third-party data provider.
